FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, in particular to new gold nanoconjugates with therapeutic agents, and can be used in medicine. The invention makes it possible to obtain a conjugate of a gold nanoparticle with doxorubicin and bombesin, in which stabilized dithiolated diethylenetriaminepentaacetic acid (DTDTPA) is bound to the surface of the gold nanoparticle, doxorubicin molecules are attached to the terminal amino groups of DTDTPA, and bombesin molecules are attached to the surface of the gold nanoparticle through the terminal thioctic acid.
EFFECT: invention discloses the possibility of using such a nanoconjugate as part of a pharmaceutical composition for targeted delivery of a therapeutic agent to tumor cells.
17 cl, 10 ex, 4 tbl, 20 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| CONJUGATE OF NANOPARTICLES OF GOLD-MAGNETITE COMPOSITION WITH FUNCTIONAL MOLECULE (OPTIONS) AND METHOD OF USE (OPTIONS) | 2023 |
|
RU2811020C1 |
| NANOPARTICLE OF GOLD-MAGNETITE COMPOSITION, METHOD OF PRODUCING NANOPARTICLE (VERSIONS), CONJUGATE BASED ON IT (VERSIONS), METHOD OF PRODUCING CONJUGATE AND TEST KIT | 2023 |
|
RU2814660C1 |
| CONJUGATE BASED ON MAGNETIC NANOPARTICLES FOR THERAPY OF SOLID TUMORS AND METHOD FOR PREPARATION THEREOF | 2023 |
|
RU2830006C1 |
| NANOAGENTS FOR SCREENING PATHOGENIC STRAINS OF MULTIDRUG-RESISTANT BACTERIA AND METHOD OF PREPARATION | 2022 |
|
RU2804488C1 |
| PEPTIDES OR THEIR PHARMACEUTICALLY ACCEPTABLE ACIDS OR SALTS, PHARMACEUTICAL COMPOSITION SHOWING ANTAGONISTIC ACTIVITY WITH RESPECT TO BOMBESINE, METHOD OF TREATMENT OF MAMMALIAN WITH CANCER | 1994 |
|
RU2114118C1 |
| METHOD AND COMPOSITION FOR TREATING CANCER | 2011 |
|
RU2541100C2 |
| THERAPEUTIC PEPTIDES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1989 |
|
RU2088592C1 |
| PEPTIDES FOR INHIBITING ANGIOGENESIS | 2016 |
|
RU2708375C2 |
| METHODS AND COMPOSITIONS FOR TUSC2-IMMUNOTHERAPY | 2017 |
|
RU2755903C2 |
| GEL COMPOSITION FOR RADIATION THERAPY UNDER VISUAL CONTROL | 2014 |
|
RU2703303C2 |
